VALENCIA, Calif.--(BUSINESS WIRE)--SetPoint Medical, a biomedical technology company developing a bioelectronic medicine therapy for inflammatory diseases, announced today the start of clinical testing to assess safety and efficacy in Crohn’s Disease, a debilitating disease caused by inflammation in the digestive tract. The trial launched as gastroenterologists gather this week in Orlando, Florida for “Advances in Inflammatory Bowel Diseases,” the Crohn’s & Colitis Foundation’s annual clinical and research conference.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
